Sculpta Bio

Sculpta is a science-first biotech startup developing RNA-based neurotherapeutics to modulate disease-associated biological pathways with higher precision and efficacy. Our CEO is a former Stanford University Assistant Professor and physician-scientist (MD/PhD) with publications in Nature, Cell, Science, etc. Our team includes accomplished scientists with expertise in RNA biology, brain organoids, transcriptomics, and machine learning. Backed by VCs with an oversubscribed pre-seed round in March 2025, we’re building a platform that will drive translational discovery and make a difference in brain health for all.